BridgeBio Oncology Therapeutics, Inc 10-Q for FY2026 Q1
BridgeBio Oncology Therapeutics, Inc. (BBOT)
10-Q
2026-05-12
For: 2026-03-31
View Original
Added on
May 12, 2026
About this 10-Q
BridgeBio Oncology Therapeutics, Inc filed this 10-Q on May 12, 2026, covering the quarter ended March 31, 2026 (FY2026 Q1).
Headline figures
Quarter ended March 31, 2026, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Net loss
- $42.11M
- compared with a net loss of $22.06M a year earlier
- Diluted EPS
- -$526.11
- compared with -$54.23 a year earlier